Comparison of risk factors for acute worsening renal function in heart failure patients with and without preserved ejection fraction.

[1]  Sanjiv J. Shah,et al.  Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction , 2014, Current Cardiology Reports.

[2]  B. Borlaug,et al.  The pathophysiology of heart failure with preserved ejection fraction , 2014, Nature Reviews Cardiology.

[3]  Talicia Tarver,et al.  HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION , 2014 .

[4]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[5]  D. Sandler,et al.  Heart Failure With Preserved Ejection Fraction , 2014 .

[6]  M. Redfield,et al.  Acute Heart Failure with Preserved Ejection Fraction: Unique Patient Characteristics and Targets for Therapy , 2013, Current Heart Failure Reports.

[7]  P. Bie,et al.  Regulation of renin secretion by renal juxtaglomerular cells , 2012, Pflügers Archiv - European Journal of Physiology.

[8]  G. Gensini,et al.  Cardiorenal Syndrome Caused by Heart Failure with Preserved Ejection Fraction , 2011, International journal of nephrology.

[9]  Nobuaki Kobayashi,et al.  Acute kidney injury and outcomes in acute decompensated heart failure: evaluation of the RIFLE criteria in an acutely ill heart failure population , 2010, European journal of heart failure.

[10]  W. Beierwaltes.  The role of calcium in the regulation of renin secretion. , 2010, American journal of physiology. Renal physiology.

[11]  R. Schrier,et al.  Cardiorenal syndrome in acute decompensated heart failure. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[12]  Daniel Levy,et al.  Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction: Insights From the Framingham Heart Study of the National Heart, Lung, and Blood Institute , 2009, Circulation.

[13]  M. Metra,et al.  Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance , 2008, European journal of heart failure.

[14]  Z. Massy,et al.  Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. , 2008, European heart journal.

[15]  V. Dzau,et al.  Molecular mechanism of juxtaglomerular cell hyperplasia: a unifying hypothesis. , 2007, Journal of the American Society of Hypertension : JASH.

[16]  V. Roger,et al.  Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.

[17]  M. Komajda,et al.  Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). , 2006, European heart journal.

[18]  C. O'connor,et al.  Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. , 2004, American heart journal.

[19]  C. O'connor,et al.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. , 2004, Journal of the American College of Cardiology.

[20]  Tom Greene,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.

[21]  H. Krumholz,et al.  Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure. , 2000, The American journal of cardiology.

[22]  J. Avorn,et al.  Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD) , 1999, American heart journal.

[23]  A. Luchner,et al.  Contribution of the endothelin system to the renal hypoperfusion associated with experimental congestive heart failure. , 1999, Journal of cardiovascular pharmacology.

[24]  Z. Abassi,et al.  Regulation of intrarenal blood flow in experimental heart failure: role of endothelin and nitric oxide. , 1998, American journal of physiology. Renal physiology.

[25]  Bertram Pitt,et al.  Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) , 1997, The Lancet.

[26]  P. Churchill,et al.  The baroreceptor mechanism for controlling renin secretion: effect of calcium channel blockers. , 1993, Journal of Pharmacology and Experimental Therapeutics.

[27]  S. Satoh,et al.  Effects of Nifedipine on Renin Release and Renal Function in Anesthetized Dogs , 1986, Journal of cardiovascular pharmacology.

[28]  M. Epstein,et al.  Nitrendipine-Induced Stimulation of Renin Release by the Isolated Perfused Rat Kidney , 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.